↓ Skip to main content

Safety, Efficacy and Pharmacokinetics of Ritonavir 400mg/Saquinavir 400mg Twice Daily plus Rifampicin Combined Therapy in HIV Patients with Tuberculosis

Overview of attention for article published in Clinical Drug Investigation, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

policy
3 policy sources

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
30 Mendeley
Title
Safety, Efficacy and Pharmacokinetics of Ritonavir 400mg/Saquinavir 400mg Twice Daily plus Rifampicin Combined Therapy in HIV Patients with Tuberculosis
Published in
Clinical Drug Investigation, August 2012
DOI 10.2165/00044011-200626080-00005
Pubmed ID
Authors

Valeria Cavalcanti Rolla, Maria A da Silva Vieira, Douglas Pereira Pinto, Maria C Lourenço, Carlos da Silva de Jesus, Mariza Gonçalves Morgado, Milton Ferreira Filho, Eduardo Werneck-Barroso

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 7%
Japan 1 3%
Unknown 27 90%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 27%
Student > Master 7 23%
Student > Postgraduate 3 10%
Student > Doctoral Student 2 7%
Other 2 7%
Other 5 17%
Unknown 3 10%
Readers by discipline Count As %
Medicine and Dentistry 13 43%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Biochemistry, Genetics and Molecular Biology 1 3%
Mathematics 1 3%
Agricultural and Biological Sciences 1 3%
Other 3 10%
Unknown 9 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2016.
All research outputs
#3,798,945
of 25,374,917 outputs
Outputs from Clinical Drug Investigation
#111
of 1,035 outputs
Outputs of similar age
#26,375
of 186,743 outputs
Outputs of similar age from Clinical Drug Investigation
#23
of 344 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,035 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,743 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 344 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.